Chong Shen, Tong Wang, Kai Li, Chong Fu, Shaobo Yang, Zhe Zhang, Zhouliang Wu, Zhi Li, Zhuolun Li, Yuda Lin, Yu Zhang, Jian Guo, Zhenqian Fan, Hailong Hu
BACKGROUND: In the realm of tumor-targeted therapeutics, Polo-like kinases (PLKs) are a significant group of protein kinases that were found recently as being related to tumors. However, the significance of PLKs in pan-cancer remains systematically studied. METHODS AND MATERIALS: We integrated multi-omics data to comprehensively investigate the expression patterns of the PLK family across various cancer types. Subsequently, study examined the associations between tumor mutation burden (TMB), microsatellite instability (MSI), immune subtype classification, immune infiltration, tumor microenvironment scores, immune checkpoint gene expression, and the PLKs expression profiles within various tumor types...
April 15, 2024: Heliyon